Delivery Order SPE2DB22D3401-SPE2DB24FT1XM
Award Date 2/15/24
Potential Completion Date 2/16/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563850465 - XCOPRI 100 MG TABLET 30S. The $1,242.66 contract has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is providing pharmaceutical products and medical supplies to support military treatment programs and facilities under this delivery order. Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XCOPRI 200 MG TABLET 30S medication. The contract has a potential value of $1,082.68 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,991.79 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a $1,623.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 100 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a ceiling value of $3,257.73 and a performance period through March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract, valued at $1,082.68, has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation. The contract...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,420.23 firm fixed price contract is for the supply of 4563755398 ! XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation and has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,936.78 order is for 150mg tablet doses of the drug XCOPRI, to be delivered by December 28, 2023. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities under previous...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a quantity of 30 tablets of the pharmaceutical drug XCOPRI 50 MG. The delivery order has a potential value of $1,082.66 and a completion date of February 15, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,623.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563171480 XCOPRI 100 MG TABLET 30S. The order was placed under an existing indefinite delivery contract and is set to be completed by December 26, 2023. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies,...